← Back to Search

Caring Text Messages for Suicide Prevention (SUNDANCE Trial)

N/A

Recruiting

Led By Dedra Buchwald, MD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Cognitively able to independently provide written informed consent

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months, 12 months

Awards & highlights

SUNDANCE Trial Summary

This trial will test if a program of caring text messages can help reduce suicide risk among at-risk AI/AN youth, compared to those who receive usual care.

Who is the study for?

This trial is for American Indian or Alaska Native youth who can read and speak English, have a text-enabled mobile phone, and are at mild to severe risk of suicidality but not in immediate danger of self-harm. They must be able to consent and participate voluntarily.Check my eligibility

What is being tested?

The study is testing the effectiveness of caring text messages (SBIRT+12) versus usual care without these messages (SBIRT+Usual Care) in reducing suicidal thoughts, attempts, hospitalizations while increasing engagement, social connectedness, and resilience among AI/AN youth.See study design

What are the potential side effects?

Since this intervention involves sending caring text messages as part of suicide prevention efforts rather than medical treatment, there are no direct physical side effects. However, emotional or psychological responses may vary individually.

SUNDANCE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am mentally capable of understanding and signing a consent form on my own.

SUNDANCE Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months, 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months, 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months, 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Hospitalizations and Behavioral Health Treatment

Change in Self-Reported Suicide Attempts

Change in Suicidal Ideation

Secondary outcome measures

Change in Social Connectedness

SBIRT Retention and Uptake of Referral to Therapy

SUNDANCE Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: SBIRT+12Experimental Treatment1 Intervention

The standard SBIRT model is augmented by a 12 month period following identification of suicide risk during which participants will receive caring text messages adapted from empirically-based, effective interventions for suicide prevention among American Indian and Alaska Native young adults.

Group II: SBIRT+Usual CarePlacebo Group1 Intervention

The control arm of the trial will receive the usual care prescribed in the Screening, Brief Intervention and Referral to Treatment (SBIRT) model.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of New MexicoOTHER

372 Previous Clinical Trials

3,528,091 Total Patients Enrolled

National Institute of Mental Health (NIMH)NIH

2,785 Previous Clinical Trials

2,689,058 Total Patients Enrolled

26 Trials studying Suicide Prevention

124,197 Patients Enrolled for Suicide Prevention

Washington State UniversityOTHER

101 Previous Clinical Trials

56,016 Total Patients Enrolled

1 Trials studying Suicide Prevention

711 Patients Enrolled for Suicide Prevention

Media Library

SBIRT+12 Clinical Trial Eligibility Overview. Trial Name: NCT03136094 — N/A

Suicide Prevention Research Study Groups: SBIRT+Usual Care, SBIRT+12

Suicide Prevention Clinical Trial 2023: SBIRT+12 Highlights & Side Effects. Trial Name: NCT03136094 — N/A

SBIRT+12 2023 Treatment Timeline for Medical Study. Trial Name: NCT03136094 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are included in the scope of this experiment?

"Indeed, according to clinicaltrials.gov, this medical trial is still open for enrollment and has been since March 15th 2020. The study was last modified April 21st 2022 and seeks 698 participants from two sites."

Answered by AI

Does the criteria for this trial encompass minors?

"This medical trial requires that applicants are aged 18 to 34. Additionally, there exist 57 trials for participants younger than the age of consent and 117 studies for individuals older than 65 years old."

Answered by AI

Is it currently feasible to enroll in this medical research experiment?

"Affirmative. Per the information housed on clinicaltrials.gov, this medical trial is actively recruiting individuals for participation. The study was first posted on March 15th 2020 and most recently updated April 21st 2022; 698 patients must be enrolled from 2 different sites."

Answered by AI

To whom is this experimental research open?

"This medical trial is aiming to enrol 698 participants, who are between 18 and 34 years old and have suicidal tendencies. In addition, these patients must also pass the following criteria: Screening positive for a mild, moderate or severe risk of suicide (as certified by a clinician); Self-identify as an American Indian/Alaska Native; Possess a text-enabled phone; Be willing to receive texts from researchers; Act voluntarily in the study; Speak and read English competently; Have cognitive capacity to give informed consent independently."

Answered by AI

Recent research and studies

American Journal of PsychiatryJournal

Contact with Mental Health and Primary Care Providers Before Suicide: A Review of the Evidence

Luoma, Jason B., Catherine E. Martin, and Jane L. Pearson. 2002. “Contact with Mental Health and Primary Care Providers Before Suicide: A Review of the Evidence”. American Journal of Psychiatry. American Psychiatric Association Publishing. doi:10.1176/appi.ajp.159.6.909.

American Journal of PsychiatryJournal

Prevalence of Mental Disorders and Utilization of Mental Health Services in Two American Indian Reservation Populations: Mental Health Disparities in a National Context

Beals, Janette, Douglas K. Novins, Nancy R. Whitesell, Paul Spicer, Christina M. Mitchell, Spero M. Manson, and American Indian Service Utilization, Psychiatric Epidemiology, Risk and Protective Factors Project Team. 2005. “Prevalence of Mental Disorders and Utilization of Mental Health Services in Two American Indian Reservation Populations: Mental Health Disparities in a National Context”. American Journal of Psychiatry. American Psychiatric Association Publishing. doi:10.1176/appi.ajp.162.9.1723.

American Journal of Public HealthJournal

Suicide Mortality Among American Indians and Alaska Natives, 1999–2009

Herne, Mose A., Michael L. Bartholomew, and Rose L. Weahkee. 2014. “Suicide Mortality Among American Indians and Alaska Natives, 1999–2009”. American Journal of Public Health. American Public Health Association. doi:10.2105/ajph.2014.301929.

JamaJournal